Cargando…

Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India

Introduction: The Revised National Tuberculosis Control Program (RNTCP) is the largest tuberculosis (TB) control program in the world based on Directly Observed Treatment Short-Course (DOTS) strategy. Globally, most countries have been using a daily regimen and in India a shift towards a daily regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Negandhi, Himanshu, Tiwari, Ritika, Sharma, Anjali, Nair, Rajesh, Zodpey, Sanjay, Reddy Allam, Ramesh, Oruganti, Ganesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496091/
https://www.ncbi.nlm.nih.gov/pubmed/28485693
http://dx.doi.org/10.1080/16549716.2017.1290315
_version_ 1783247899988066304
author Negandhi, Himanshu
Tiwari, Ritika
Sharma, Anjali
Nair, Rajesh
Zodpey, Sanjay
Reddy Allam, Ramesh
Oruganti, Ganesh
author_facet Negandhi, Himanshu
Tiwari, Ritika
Sharma, Anjali
Nair, Rajesh
Zodpey, Sanjay
Reddy Allam, Ramesh
Oruganti, Ganesh
author_sort Negandhi, Himanshu
collection PubMed
description Introduction: The Revised National Tuberculosis Control Program (RNTCP) is the largest tuberculosis (TB) control program in the world based on Directly Observed Treatment Short-Course (DOTS) strategy. Globally, most countries have been using a daily regimen and in India a shift towards a daily regimen for TB treatment has already begun. The daily strategy is known to improve program coverage along with compliance. Such strategic shifts have both management and operational implications. We undertook a rapid assessment to understand the facilitators and barriers in adopting the daily regimen for TB treatment in three Indian states. Methods: In-depth interviews were planned across six districts of three purposively selected states of Maharashtra, Bihar and Sikkim, among health system personnel at various levels to identify their perspectives on adoption of a daily regimen for TB. These districts were sampled on the basis of TB notification rates. Thematic analysis of the qualitative data was undertaken. Results: 62 respondents were interviewed from these 6 districts. During the analysis, it was observed that an easily accessible, patient-centred and personalized outreach is an enabling factor for adherence to treatment. Lack of transportation facilities, out-of-pocket expenses and loss of wages for accessing DOTS at institutions are major identified barriers for treatment adherence at individual level. At program level, lack of trained service providers, poor administration of treatment protocols and inadequate supervision by health care providers and program managers are key factors that influence program outcomes. Conclusion: A major observation that emerged from the interviews is that the key to achieve a relapse-free cure is ensuring that a patient receives all doses of the prescribed treatment regimen. However, switching to a daily regimen makes adherence difficult and thus new strategies are needed for its implementation at patient and health provider levels. Most stakeholders appreciate the reasons for switching to a daily regimen. The stakeholders recognised the efforts of the Ministry of Health & Family Welfare (MoHFW) in spearheading the program. Strategies like the 99 DOTS call-centre approach may also further ensure treatment adherence.
format Online
Article
Text
id pubmed-5496091
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-54960912017-07-11 Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India Negandhi, Himanshu Tiwari, Ritika Sharma, Anjali Nair, Rajesh Zodpey, Sanjay Reddy Allam, Ramesh Oruganti, Ganesh Glob Health Action Original Article Introduction: The Revised National Tuberculosis Control Program (RNTCP) is the largest tuberculosis (TB) control program in the world based on Directly Observed Treatment Short-Course (DOTS) strategy. Globally, most countries have been using a daily regimen and in India a shift towards a daily regimen for TB treatment has already begun. The daily strategy is known to improve program coverage along with compliance. Such strategic shifts have both management and operational implications. We undertook a rapid assessment to understand the facilitators and barriers in adopting the daily regimen for TB treatment in three Indian states. Methods: In-depth interviews were planned across six districts of three purposively selected states of Maharashtra, Bihar and Sikkim, among health system personnel at various levels to identify their perspectives on adoption of a daily regimen for TB. These districts were sampled on the basis of TB notification rates. Thematic analysis of the qualitative data was undertaken. Results: 62 respondents were interviewed from these 6 districts. During the analysis, it was observed that an easily accessible, patient-centred and personalized outreach is an enabling factor for adherence to treatment. Lack of transportation facilities, out-of-pocket expenses and loss of wages for accessing DOTS at institutions are major identified barriers for treatment adherence at individual level. At program level, lack of trained service providers, poor administration of treatment protocols and inadequate supervision by health care providers and program managers are key factors that influence program outcomes. Conclusion: A major observation that emerged from the interviews is that the key to achieve a relapse-free cure is ensuring that a patient receives all doses of the prescribed treatment regimen. However, switching to a daily regimen makes adherence difficult and thus new strategies are needed for its implementation at patient and health provider levels. Most stakeholders appreciate the reasons for switching to a daily regimen. The stakeholders recognised the efforts of the Ministry of Health & Family Welfare (MoHFW) in spearheading the program. Strategies like the 99 DOTS call-centre approach may also further ensure treatment adherence. Taylor & Francis 2017-05-09 /pmc/articles/PMC5496091/ /pubmed/28485693 http://dx.doi.org/10.1080/16549716.2017.1290315 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Negandhi, Himanshu
Tiwari, Ritika
Sharma, Anjali
Nair, Rajesh
Zodpey, Sanjay
Reddy Allam, Ramesh
Oruganti, Ganesh
Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India
title Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India
title_full Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India
title_fullStr Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India
title_full_unstemmed Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India
title_short Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India
title_sort rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496091/
https://www.ncbi.nlm.nih.gov/pubmed/28485693
http://dx.doi.org/10.1080/16549716.2017.1290315
work_keys_str_mv AT negandhihimanshu rapidassessmentoffacilitatorsandbarriersrelatedtotheacceptancechallengesandcommunityperceptionofdailyregimenfortreatingtuberculosisinindia
AT tiwariritika rapidassessmentoffacilitatorsandbarriersrelatedtotheacceptancechallengesandcommunityperceptionofdailyregimenfortreatingtuberculosisinindia
AT sharmaanjali rapidassessmentoffacilitatorsandbarriersrelatedtotheacceptancechallengesandcommunityperceptionofdailyregimenfortreatingtuberculosisinindia
AT nairrajesh rapidassessmentoffacilitatorsandbarriersrelatedtotheacceptancechallengesandcommunityperceptionofdailyregimenfortreatingtuberculosisinindia
AT zodpeysanjay rapidassessmentoffacilitatorsandbarriersrelatedtotheacceptancechallengesandcommunityperceptionofdailyregimenfortreatingtuberculosisinindia
AT reddyallamramesh rapidassessmentoffacilitatorsandbarriersrelatedtotheacceptancechallengesandcommunityperceptionofdailyregimenfortreatingtuberculosisinindia
AT orugantiganesh rapidassessmentoffacilitatorsandbarriersrelatedtotheacceptancechallengesandcommunityperceptionofdailyregimenfortreatingtuberculosisinindia